David Mayer (@djmventure), who has worked as a Boston-based partner with healthcare and life science venture capital firm Abingworth, is starting his own health IT investment business.
Mayer Investors is scheduled to go live March 1. The healthcare investor will target technology-enabled services providers developing cloud-based solutions for healthcare payer, provider, life sciences and consumer markets, according to the website.
“Our investment efforts are principally centered on expansion-stage venture capital and growth equity financings for B2B software-as-a-service business models in healthcare and healthcare related markets.”
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Mayer mentioned his new business on Twitter. The website is currently under construction.
New chapter for me starting March 1 http://t.co/3sm8LhRLwZ Check back for full site and first blog post “Why did I form Mayer Investors?”
— David Mayer (@djmventure) February 4, 2014
Mayer has worked at Abingworth since 2008 and has focused on growth equity including growth capital and growth buyouts in healthcare IT, medical technology and technology enabled services, according to CrunchBase. Among the companies where he has held a seat on the board are medical device company Atritech, Jazz Pharmaceuticals and Essent Healthcare, a company which manages a network of hospitals.
